79 Krinitzi st.
Purchase of Inhalation Equipment
CF patients are subject to frequent lung infections and an overall deterioration of lung function. Since the eventual collapse of the lungs is the main cause of death among CF patients, treatment focuses mainly on lung issues such as the clearing of airways and the prevention of infections.
In order to fight inflammation and ease breathing, bronchial tube-widening, antibiotic and expectorant medications are often administered through an inhalation process which inserts lotions into the lungs and enables the softening and evacuation of sputum. Each CF patient must undergo four inhalation treatments per day with each treatment lasting some thirty minutes.
The process of inhalation enables the transfer of medicine directly to the lung without any of the medication being absorbed in the blood system. This enables caregivers to lower the dosage of medicine which in turn reduces the impact of side effects on the patients’ overall health. In addition, the direct delivery of medicine to the lung reduces the duration of the inhalation treatment.
CF patients make use of two types of inhalation equipment: institutional equipment found in CF clinics and home devices used daily by the patient in his home.
The IPV institutional inhaler, which is used in hospitals and CF clinics, is a more sophisticated and powerful inhaler then the one used by patients in the home. At home, each CF patient has his own inhaler. Due to the nature of the illness and the high risk of contagion, these devices may not be transferred from one patient to another. Given the fact the home inhaler is used by all patients four times a day, it requires continuous upkeep and must be replaced every 2-3 years.
Currently, there are two types of home inhalers used by CF patients: the Pari Turbo inhaler and the e-Flow Rapid inhaler. While the Pari Turbo inhaler has recently been added to medical insurance packages and is therefore partially subsidized, the much more sophisticated e-Flow Rapid inhaler can only be purchased at full price. This inhaler reduces treatment time by some 50% and is completely mobile, quite and discrete. Thus, it is an innovative inhaler that may be used by patients anytime and anywhere thereby increasing their independence and ability to lead rich and full lives despite their chronic illness.
The Cystic Fibrosis Foundation of Israel is interested in purchasing 6 new IVP machines of our CF clinics and 200 new inhalers for home use which shall be distributed to patients from underprivileged families who cannot afford to buy a personal inhaler.
Please press the following the link and donate to this important cause.
You can also contact us directly at: email@example.com